|Articles|November 1, 2003

Study recommends 4-year screening interval for PCa

Author(s)Cheryl Guttman Krader, BS, Pharm

Rotterdam, Netherlands-Four years is a reasonable interval for prostatecancer screening, concluded investigators from the European Randomized Studyof Screening for Prostate Cancer (ERSPC).

Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.

Latest CME

Video

Burst CME™: Staying Informed and Up-To-Date on the Treatment of Lupus Nephritis

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Video

Burst CME™: Recognizing Lupus Nephritis—From Timely Diagnosis to Appreciating the Underlying Mechanisms of Disease

Michelle Petri, MD, MPH; Shivani Garg, MD, PhD

Study recommends 4-year screening interval for PCa

Related Content

Jessica Yih, MD, highlights data on testosterone therapy in women

Blue light cystoscopy is tied to higher resource use, not health care cost, in NMIBC

Real-world data support PSA below 0.2 ng/mL as key response threshold in mCSPC

The AUA Clinically Localized Prostate Cancer guideline: FAQs for urologists

Published data show rPFS benefit with lutetium Lu 177 vipivotide tetraxetan in mHSPC